FI860153A0 - Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning. - Google Patents

Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.

Info

Publication number: FI860153A0
Authority: FI; Finland
Prior art keywords: deras; oligopeptider; mellanprodukter; foerfarande foer; framstaellning
Prior art date: 1985-01-16

Application number

FI860153A

Other languages

English (en)

Other versions

FI86547C (fi

FI86547B (fi

FI860153L (fi

Inventor

Hendrik Simons Jansz

Cornelis Josephus Maria Lips

Paul Herman Steenbergh

Hans Rink

Peter Sieber

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-01-16

Filing date

1986-01-13

Publication date

1986-01-13

1986-01-13 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1986-01-13 Publication of FI860153A0 publication Critical patent/FI860153A0/fi

1986-07-17 Publication of FI860153L publication Critical patent/FI860153L/fi

1992-05-29 Application granted granted Critical

1992-05-29 Publication of FI86547B publication Critical patent/FI86547B/fi

1992-09-10 Publication of FI86547C publication Critical patent/FI86547C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57527—Calcitonin gene related peptide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FI860153A 1985-01-16 1986-01-13 Foerfarande foer framstaellning av en peptid som verkar farmakologiskt pao hjaercirkulationen eller skelettaemnesomsaettningen. FI86547C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH18885		1985-01-16
CH18885		1985-01-16

Publications (4)

Publication Number	Publication Date
FI860153A0 true FI860153A0 (fi)	1986-01-13
FI860153L FI860153L (fi)	1986-07-17
FI86547B FI86547B (fi)	1992-05-29
FI86547C FI86547C (fi)	1992-09-10

Family

ID=4181264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI860153A FI86547C (fi)	1985-01-16	1986-01-13	Foerfarande foer framstaellning av en peptid som verkar farmakologiskt pao hjaercirkulationen eller skelettaemnesomsaettningen.

Country Status (12)

Country	Link
US (1)	US4720483A (fi)
EP (1)	EP0188400B1 (fi)
JP (1)	JPH0780908B2 (fi)
AT (1)	ATE78040T1 (fi)
CA (1)	CA1339365C (fi)
DE (1)	DE3685885D1 (fi)
DK (1)	DK17986A (fi)
ES (2)	ES8707974A1 (fi)
FI (1)	FI86547C (fi)
GR (1)	GR860081B (fi)
IE (1)	IE58190B1 (fi)
PT (1)	PT81837B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5221518A (en) *	1984-12-14	1993-06-22	Mills Randell L	DNA sequencing apparatus
GB8720115D0 (en) *	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
DE3888357T2 (de) *	1987-06-22	1994-09-15	Merck & Co Inc	Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
US5266561A (en) *	1988-01-11	1993-11-30	Amylin Pharmaceuticals, Inc.	Treatment of type 2 diabetes mellitus
AU629552B2 (en) *	1988-06-16	1992-10-08	Teijin Limited	S-sulfonated calcitonin derivatives
US5175145A (en) *	1988-08-26	1992-12-29	Amylin Pharmaceuticals, Inc.	Treatment of diabetes mellitus with amylin agonists
GB8829432D0 (en) *	1988-12-15	1989-02-01	Celltech Ltd	Enzymatic process
EP0448513A3 (en) *	1990-03-21	1991-12-27	Japat Ltd	Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
WO1993002697A1 (en) *	1991-08-08	1993-02-18	Amylin Pharmaceuticals, Inc.	Production of peptide amides
US5569604A (en) *	1993-09-03	1996-10-29	The University Of Iowa Research Foundation	Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins
US9096636B2 (en) *	1996-06-06	2015-08-04	Isis Pharmaceuticals, Inc.	Chimeric oligomeric compounds and their use in gene modulation
US20040147022A1 (en) *	1996-06-06	2004-07-29	Baker Brenda F.	2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) *	1996-06-06	1999-04-27	Isis Pharmaceuticals, Inc.	Oligoribonucleotides for cleaving RNA
US20050053976A1 (en) *	1996-06-06	2005-03-10	Baker Brenda F.	Chimeric oligomeric compounds and their use in gene modulation
US20050042647A1 (en) *	1996-06-06	2005-02-24	Baker Brenda F.	Phosphorous-linked oligomeric compounds and their use in gene modulation
US20050119470A1 (en) *	1996-06-06	2005-06-02	Muthiah Manoharan	Conjugated oligomeric compounds and their use in gene modulation
US20040203024A1 (en) *	1996-06-06	2004-10-14	Baker Brenda F.	Modified oligonucleotides for use in RNA interference
US7812149B2 (en) *	1996-06-06	2010-10-12	Isis Pharmaceuticals, Inc.	2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US20040171031A1 (en) *	1996-06-06	2004-09-02	Baker Brenda F.	Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
AU725954B2 (en) *	1996-08-15	2000-10-26	Board Of Trustees Of Southern Illinois University, The	Enhancement of antimicrobial peptide activity by metal ions
DE19652033A1 (de) *	1996-12-13	1998-06-18	Irmgard Dr Med Guertner	Neuropeptid (CGRP) als Modulator zur Zelldifferenzierung und Proliferation
WO2004044136A2 (en) *	2002-11-05	2004-05-27	Isis Pharmaceuticals, Inc.	Compositions comprising alternating 2’-modified nucleosides for use in gene modulation
US20060241072A1 (en) *	2003-06-20	2006-10-26	Isis Pharmaceuticals, Inc.	Oligomeric compounds for use in gene modulation
EP1703916A2 (en)	2004-01-13	2006-09-27	Vasogenix Pharmaceuticals, Inc.	Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
JP2007517912A (ja) *	2004-01-13	2007-07-05	バソジェニックスファーマシューティカルズ，インコーポレイテッド	心脈管および腎臓の適応症のための制御放出ｃｇｒｐ送達組成物
WO2005070444A2 (en) *	2004-01-13	2005-08-04	Vasogenix Pharmaceuticals, Inc.	Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
US8569474B2 (en) *	2004-03-09	2013-10-29	Isis Pharmaceuticals, Inc.	Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) *	2004-06-03	2013-03-12	Isis Pharmaceuticals, Inc.	Positionally modified siRNA constructs
JP2008501693A (ja) *	2004-06-03	2008-01-24	アイシスファーマシューティカルズ、インク．	遺伝子調節で使用するための個別に調節された鎖を有する二本鎖組成物
US7884086B2 (en) *	2004-09-08	2011-02-08	Isis Pharmaceuticals, Inc.	Conjugates for use in hepatocyte free uptake assays
US8168592B2 (en) *	2005-10-21	2012-05-01	Amgen Inc.	CGRP peptide antagonists and conjugates
JP4884193B2 (ja) *	2006-12-15	2012-02-29	ヤマハ発動機株式会社	船舶
US8835379B2 (en)	2009-10-30	2014-09-16	Novo Nordisk A/S	Derivatives of CGRP
CA2846234A1 (en) *	2011-08-22	2013-02-28	Suganit Systems, Inc.	Production of bio-butanol and related products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5374618A (en) *	1983-06-15	1994-12-20	Celltech Limited	Calcitonin peptides, and gene related pharmaceutical compositions
US4530838A (en) *	1983-07-08	1985-07-23	The Salk Institute For Biological Studies	Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
GB8327346D0 (en) *	1983-10-12	1983-11-16	Morris H R	Peptide
US4549986A (en) *	1983-12-23	1985-10-29	The Salk Institute For Biological Studies	Human CGRP

1986
- 1986-01-10 DE DE8686810007T patent/DE3685885D1/de not_active Expired - Lifetime
- 1986-01-10 AT AT86810007T patent/ATE78040T1/de not_active IP Right Cessation
- 1986-01-10 EP EP86810007A patent/EP0188400B1/de not_active Expired - Lifetime
- 1986-01-13 FI FI860153A patent/FI86547C/fi not_active IP Right Cessation
- 1986-01-14 CA CA000499545A patent/CA1339365C/en not_active Expired - Lifetime
- 1986-01-14 PT PT81837A patent/PT81837B/pt not_active IP Right Cessation
- 1986-01-14 GR GR860081A patent/GR860081B/el unknown
- 1986-01-14 JP JP61006159A patent/JPH0780908B2/ja not_active Expired - Lifetime
- 1986-01-15 DK DK17986A patent/DK17986A/da not_active Application Discontinuation
- 1986-01-15 IE IE11686A patent/IE58190B1/en not_active IP Right Cessation
- 1986-01-15 US US06/819,168 patent/US4720483A/en not_active Expired - Lifetime
- 1986-01-15 ES ES550911A patent/ES8707974A1/es not_active Expired
1987
- 1987-01-14 ES ES557315A patent/ES8802161A1/es not_active Expired

Also Published As

Publication number	Publication date
ES8802161A1 (es)	1988-04-01
CA1339365C (en)	1997-08-26
US4720483A (en)	1988-01-19
JPH0780908B2 (ja)	1995-08-30
EP0188400B1 (de)	1992-07-08
GR860081B (en)	1986-04-29
IE860116L (en)	1986-07-16
DE3685885D1 (de)	1992-08-13
ES550911A0 (es)	1987-09-01
ATE78040T1 (de)	1992-07-15
DK17986D0 (da)	1986-01-15
JPS61172899A (ja)	1986-08-04
FI86547C (fi)	1992-09-10
ES8707974A1 (es)	1987-09-01
PT81837A (en)	1986-02-01
IE58190B1 (en)	1993-07-28
EP0188400A3 (en)	1988-08-31
ES557315A0 (es)	1988-04-01
DK17986A (da)	1986-07-17
EP0188400A2 (de)	1986-07-23
FI86547B (fi)	1992-05-29
FI860153L (fi)	1986-07-17
PT81837B (pt)	1988-05-27

Publication	Publication Date	Title
FI860153A0 (fi)	1986-01-13	Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.
FI953658A0 (fi)	1995-08-01	Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia
DK382786A (da)	1986-10-13	Overfladeaktivt rekombinant-alveolarprotein
DK0535091T3 (da)	1996-05-06	Knogleinducerende farmaceutiske formuleringer
RU95115239A (ru)	1997-03-27	Аналог эритропоэтина
DK0792287T3 (da)	2004-08-30	Peptidanaloger af humant basisk myelinprotein
ATE108662T1 (de)	1994-08-15	Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
ATE213499T1 (de)	2002-03-15	Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
ES2114555T3 (es)	1998-06-01	Nuevo interferon gamma humano recombinado.
ATE93527T1 (de)	1993-09-15	Peptide und deren benutzung.
DK0422215T3 (da)	1999-05-25	Antibakterielle peptider og antimalariapeptider
DK595187A (da)	1988-07-21	Minactivin og fremgangsmaade til fremstilling deraf
ATE452903T1 (de)	2010-01-15	Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DK0423326T3 (da)	1999-05-25	Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
DK547486A (da)	1987-06-17	Peptider samt praeparater indeholdende disse

Legal Events

Date	Code	Title	Description
1994-04-21	PC	Transfer of assignment of patent	Owner name: CELLTECH LIMITED
1996-08-15	MM	Patent lapsed
2004-08-31	MM	Patent lapsed	Owner name: CELLTECH LIMITED